mRNA |
Bosutinib |
FIMM |
pan-cancer |
AAC |
-0.31 |
0.4 |
mRNA |
BRD-K07442505 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
JQ-1 |
GDSC1000 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.4 |
mRNA |
phenformin |
GDSC1000 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
Epothilone B |
FIMM |
pan-cancer |
AAC |
-0.15 |
0.4 |